Home Home Home Inbox Home Search

Event

Justification of the Inhalation Parameters to Provide Patients with Dose Confirmation Feedback When They Use a Digitally Enabled Albuterol Multidose Dry Powder Inhaler (eMDPI) [Board No. P998]

Location: Board no. P998
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Guilherme Safioti

MD
Teva Pharmaceutical Industries

Henry Chrystyn

PhD
Inhalation Consultancy Ltd

Dan Buck

M.Eng.
Teva Pharmaceutical Industries

Frank Ruiter

MSc
Teva Pharmachemie

Julian Blair

PhD
Teva Pharmaceutical Industries

View Abstract

Justification of the Inhalation Parameters to Provide Patients with Dose Confirmation Feedback When They Use a Digitally Enabled Albuterol Multidose Dry Powder Inhaler (eMDPI)

Parent Sessions

  • B65 - ASTHMA: PATHOPHYSIOLOGY AND CLINICAL TRIALS...
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search